机译:Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?
Erasmus Univ, Inst Med Technol Assessment, POB 1738, NL-3000 DR Rotterdam, Netherlands;
IMS Hlth, Hlth Econ & Outcomes Res, London, England;
Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, ScotlandSwedish Inst Hlth Econ, Lund, SwedenNatl Ctr Resp Pharmacoecon & Pharmacoepidemiol CE, Verona, ItalyUniv Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USAUmea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, SwedenComprehens Pneumol Ctr Munich, German Ctr Lung Res, Helmholtz Zentrum Munchen, Inst Hlth Econ &ICON Hlth Econ, Toronto, ON, CanadaNatl Inst Publ Hlth & Environm RIVM, Dept Prevent & Hlth Serv Res, Bilthoven, Netherlands;